Sonidegib improved quality of life in patients with advanced basal cell carcinoma: Results from the phase 2 Basal cell carcinoma outcomes with LDE225 treatment trial through 73 weeks

Bibliographic Details
Main Authors: Michael Migden, MD, Carmen Loquai, MD, PhD, Caroline Robert, MD, PhD, Jean-François Baurain, MD, PhD, Nicholas Squittieri, MD, Ramon Arntz, Dr, Jörg Dierlamm, BSc, Brigitte Dréno, MD, PhD
Format: Article
Language:English
Published: Elsevier 2023-03-01
Series:JAAD International
Online Access:http://www.sciencedirect.com/science/article/pii/S2666328722001365

Similar Items